The authors contributed equally to this research
Research Article
Anti-Inflammatory and PPAR Transactivational Properties of Flavonoids from the Roots of Sophora flavescens
Article first published online: 30 OCT 2012
DOI: 10.1002/ptr.4871
Copyright © 2012 John Wiley & Sons, Ltd.
Issue

Phytotherapy Research
Early View (Online Version of Record published before inclusion in an issue)
Additional Information
How to Cite
Quang, T. H., Ngan, N. T. T., Minh, C. V., Kiem, P. V., Tai, B. H., Nhiem, N. X., Thao, N. P., Luyen, B. T. T., Yang, S. Y. and Kim, Y. H. (2012), Anti-Inflammatory and PPAR Transactivational Properties of Flavonoids from the Roots of Sophora flavescens. Phytother. Res.. doi: 10.1002/ptr.4871
- †
The authors contributed equally to this research
Publication History
- Article first published online: 30 OCT 2012
- Manuscript Accepted: 3 OCT 2012
- Manuscript Revised: 5 SEP 2012
- Manuscript Received: 31 MAY 2012
Funded by
- Ministry of Education, Science and Technology. Grant Number: 2009-0093815
- Abstract
- Article
- References
- Cited By
Keywords:
- Sophora flavescens;
- Leguminosae;
- Flavonoid, NF-κB-luciferase assay;
- RT-PCR;
- PPRE-luciferase assay
Anti-inflammatory and peroxisome proliferator-activated receptors (PPARs) transactivational effects of nine compounds (1 − 9) from the roots of Sophora flavescens were evaluated using NF-κB-luciferase, reverse transcriptase polymerase chain reaction, peroxisome proliferator response element (PPRE)-luciferase, and GAL-4-PPAR chimera assays. Compounds 4 and 8 significantly inhibited TNFα-induced NF-κB transcriptional activity in HepG2 cells in a dose-dependent manner, with IC50 values of 4.0 and 4.4 μM, respectively. Furthermore, the transcriptional inhibitory function of these compounds was confirmed by a decrease in cyclooxgenase 2 and inducible nitric oxide synthase gene expression levels in HepG2 cells. Compounds 1, 3, 5, 6, 8, and 9 significantly activated the transcription of PPARs in a dose-dependent manner, with EC50 values ranging from 1.1 to 13.0 μM. Compounds 1, 3, 5, 6, 8, and 9 exhibited dose-dependent PPARα transactivational activity, with EC50 values in a range of 0.9 − 16.0 μM. Compounds 1, 3, 8, and 9 also significantly upregulated PPARγ activity in a dose-dependent manner, with EC50 values of 10.5, 6.6, 15.7, and 1.6 μM, whereas compounds 1, 8, and 9 demonstrated transactivational PPARβ(δ) effects with EC50 values of 11.4, 10.3, and 1.5 μM, respectively. These results provide a scientific rationale for the use of the roots of S. flavescens and warrant further studies to develop new agents for the prevention and treatment of inflammatory and metabolic diseases. Copyright © 2012 John Wiley & Sons, Ltd.

1099-1573/asset/PTR_left.gif?v=1&s=61679c959d6ba2d597f752341613b4d11f86e770)
1099-1573/asset/PTR_right.gif?v=1&s=9ab10d74d00053b89129ee4003616901d34ded47)